BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 29548760)

  • 1. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
    Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
    Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
    Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
    Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the adverse effects of clozapine: focus on myocarditis.
    De Berardis D; Serroni N; Campanella D; Olivieri L; Ferri F; Carano A; Cavuto M; Martinotti G; Cicconetti A; Piersanti M; Saverio Moschetta F; Di Giannantonio M
    Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine.
    Wehmeier PM; Schüler-Springorum M; Heiser P; Remschmidt H
    J Child Adolesc Psychopharmacol; 2004; 14(2):267-71. PubMed ID: 15319023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].
    Kamphuis H; Arends J; Timmerman L; van Marle J; Kappert J
    Tijdschr Psychiatr; 2010; 52(4):223-33. PubMed ID: 20503163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early recognition of clozapine-induced myocarditis.
    Annamraju S; Sheitman B; Saik S; Stephenson A
    J Clin Psychopharmacol; 2007 Oct; 27(5):479-83. PubMed ID: 17873680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ
    Aust N Z J Psychiatry; 2011 Jun; 45(6):458-65. PubMed ID: 21524186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience.
    Murch S; Tran N; Liew D; Petrakis M; Prior D; Castle D
    Australas Psychiatry; 2013 Jun; 21(3):258-61. PubMed ID: 23439546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse cardiac effects associated with clozapine.
    Merrill DB; Dec GW; Goff DC
    J Clin Psychopharmacol; 2005 Feb; 25(1):32-41. PubMed ID: 15643098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.
    Reinders J; Parsonage W; Lange D; Potter JM; Plever S
    Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine associated cardiotoxicity: Issues, challenges and way forward.
    Kanniah G; Kumar S
    Asian J Psychiatr; 2020 Apr; 50():101950. PubMed ID: 32109805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of clozapine-induced myocarditis.
    Bellissima BL; Tingle MD; Cicović A; Alawami M; Kenedi C
    Int J Cardiol; 2018 May; 259():122-129. PubMed ID: 29579587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Schulte PF
    Tijdschr Psychiatr; 2011; 53(3):193-4. PubMed ID: 21404176
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocarditis and cardiomyopathy associated with clozapine.
    Kilian JG; Kerr K; Lawrence C; Celermajer DS
    Lancet; 1999 Nov; 354(9193):1841-5. PubMed ID: 10584719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy.
    Siskind D; Sidhu A; Cross J; Chua YT; Myles N; Cohen D; Kisely S
    Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of clozapine safety.
    Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S
    Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein: an early critical sign of clozapine-related myocarditis.
    Fehily SR; Forlano R; Fitzgerald PB
    Australas Psychiatry; 2016 Apr; 24(2):181-4. PubMed ID: 26400456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.
    Youssef DL; Narayanan P; Gill N
    Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Cohen D
    Tijdschr Psychiatr; 2010; 52(10):727-8; author reply 728-9. PubMed ID: 20931487
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis.
    Vickers M; Ramineni V; Malacova E; Eriksson L; McMahon K; Moudgil V; Scott J; Siskind D
    Acta Psychiatr Scand; 2022 May; 145(5):442-455. PubMed ID: 35067911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.